Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-Prospective, randomized, double-blind, placebo-controlled study. [electronic resource]
Producer: 20191011Description: 2226-2233 p. digitalISSN:- 1520-6777
- Acetanilides -- adverse effects
- Adolescent
- Adult
- Aged
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Patient Reported Outcome Measures
- Prospective Studies
- Thiazoles -- adverse effects
- Treatment Outcome
- Urinary Bladder, Overactive -- drug therapy
- Urodynamics -- drug effects
- Urological Agents -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.